oncology therapeutics
SyzOnc has raised $800K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2024.
SyzOnc's investors include BrightEdge - American Cancer Society.
SyzOnc is headquartered in Philadelphia, United States.
oncology therapeutics
SyzOnc is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SyzOnc — Funding & Investors." VCBacked, April 5, 2024, https://www.vcbacked.co/company/syzonc. Accessed August 2, 2026.
VCBacked. (2024). SyzOnc — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/syzonc
{{cite web |title=SyzOnc — Funding & Investors |url=https://www.vcbacked.co/company/syzonc |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated